Macrogenics Q1 EPS $(0.65) Beats $(0.76) Estimate, Sales $13.19M Beat $6.17M Estimate

Author: Benzinga Newsdesk | May 13, 2025 03:21pm
Macrogenics (NASDAQ:MGNX) reported quarterly losses of $(0.65) per share which beat the analyst consensus estimate of $(0.76) by 14.47 percent. This is a 22.62 percent increase over losses of $(0.84) per share from the same period last year. The company reported quarterly sales of $13.19 million which beat the analyst consensus estimate of $6.17 million by 113.92 percent. This is a 44.90 percent increase over sales of $9.10 million the same period last year.

Posted In: MGNX